OpGen | 10-Q: FY2025 Q1 Revenue: USD 0

Revenue: As of FY2025 Q1, the actual value is USD 0.

EPS: As of FY2025 Q1, the actual value is USD -0.04.

Segment Revenue

• Product Sales: $0 for the three months ended March 31, 2025, compared to $141,373 for the same period in 2024.
• Laboratory Services: $0 for the three months ended March 31, 2025, compared to $26,776 for the same period in 2024.
• Listing Sponsorship Services: $0 for the three months ended March 31, 2025, compared to $0 for the same period in 2024.

Operational Metrics

• Operating Loss: -$522,846 for the three months ended March 31, 2025, compared to -$1,745,315 for the same period in 2024.
• Net Income (Loss): -$408,133 for the three months ended March 31, 2025, compared to $287,967 for the same period in 2024.

Cash Flow

• Net Cash Used in Operating Activities: -$197,872 for the three months ended March 31, 2025, compared to -$1,084,050 for the same period in 2024.
• Net Cash Provided by Financing Activities: $0 for the three months ended March 31, 2025, compared to $199,720 for the same period in 2024.

Unique Metrics

• Investment in Equity Securities: The company holds an investment valued at $5.0 million in equity securities of a privately held entity, received as consideration for services rendered.

Future Outlook and Strategy

• Core Business Focus: The company plans to fund operations primarily through financing arrangements with AEI Capital Ltd., including the August 2024 Securities Purchase Agreement, which allows the company to sell shares of common stock up to $9.0 million until December 31, 2025.
• Non-Core Business: The company has repositioned itself to operate in the financial services and technology industry, forming CapForce International Holdings Ltd. to offer listing sponsorship and consultancy services and enter the financial technology industry.

Priority

• The company emphasizes strategic collaboration through a joint venture with the European Credit Investment Bank to develop and operate a stock trading platform and digital investment banking platform across Asia and globally.